Skip to content

Advancing the Standard of Care for Pin Site Care

Advancing the Standard of Care for Pin Site Care: Prospective Single Center Study Using Medihoney HCS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01965665
Enrollment
20
Registered
2013-10-18
Start date
2013-10-31
Completion date
2015-06-30
Last updated
2016-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Open Reduction External Fixation

Keywords

Diabetes, Surgical Intervention, Honey

Brief summary

The purpose of this study is to prospectively evaluate the effect of Active Leptospermum honey utilizing the MediHoney HCS dressing, on the occurrence of PIN site infections, and also to see if the use of MediHoney HCS reduces the frequency of dressing changes compared to published reports of routine standard pin site care.

Detailed description

Up to 20 Diabetic Mellitus patients undergoing Open Reduction External Fixation (OREF) for foot and/or ankle fusions, fracture repair, or osteotomy will be enrolled to receive weekly Medihoney pin site care until frame removal. Standard size dressings and application technique will be used at each pin site with prefabricated materials. No procedures, tests or interventions will be performed exclusively for research purposes or more frequently than the standard of care. Upon completion of the study, pin sites sepsis rates will be compared to published reports for standard pin site care.

Interventions

DEVICEMediHoney HCS dressing

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* A signed and dated informed consent has been obtained from the subject. * Subject is able and willing to comply with study procedures. * Subject is 18 years of age or older. * Type I or II Diabetes * Albumin \>2.5 * A1C\<12 or average fasting levels \<200 * ABI \> .6 or biphasic pedal vessels by Doppler * Charcot arthropathy of lower extremity * Foot/ankle deformity * Foot/ankle fracture * Subject will undergo an Open Reduction with External Fixation (OREF).

Exclusion criteria

* A1C \> 12 * ABI \< .6 or monophasic pedal pulses on Doppler * Recent (\<2 months) or ongoing bone infection based on radiograph or scan * Cellulitis of lower extremity within the last 2 months based on clinical exam and/or laboratory markers * Honey or honey based allergy

Design outcomes

Primary

MeasureTime frameDescription
Total Number of Pin SitesDay of surgical intervention approximately 3hrs.total number of pin sites for all patients enrolled
Number of Patients With Pin Site Infectionweekly from baseline until frame removal, up to 16 weeksPatients will be assessed weekly for pin site infection up until frame removal.
Change in Sepsis Rateweekly from baseline until frame removal, up to 16 weeksPatients will be assessed weekly for sepsis or until frame is removed.

Countries

United States

Participant flow

Participants by arm

ArmCount
Medihoney HCS Dressing
weekly Medihoney pin site care until frame removal. Standard size dressings and application technique will be used at each pin site with prefabricated materials. MediHoney HCS dressing
20
Total20

Baseline characteristics

CharacteristicMedihoney HCS Dressing
Age, Continuous58 years
STANDARD_DEVIATION 9.5
Sex: Female, Male
Female
4 Participants
Sex: Female, Male
Male
16 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
1 / 19
serious
Total, serious adverse events
1 / 19

Outcome results

Primary

Change in Sepsis Rate

Patients will be assessed weekly for sepsis or until frame is removed.

Time frame: weekly from baseline until frame removal, up to 16 weeks

Population: Data not collected

Primary

Number of Patients With Pin Site Infection

Patients will be assessed weekly for pin site infection up until frame removal.

Time frame: weekly from baseline until frame removal, up to 16 weeks

ArmMeasureValue (NUMBER)
Medihoney HCS DressingNumber of Patients With Pin Site Infection3 participants
Primary

Total Number of Pin Sites

total number of pin sites for all patients enrolled

Time frame: Day of surgical intervention approximately 3hrs.

ArmMeasureValue (NUMBER)
Medihoney HCS DressingTotal Number of Pin Sites244 total number of pin sites

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026